BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32585221)

  • 21. Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause.
    Ferris JS; Suzuki Y; Prest MT; Chen L; Elkin EB; Hur C; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2024 Jun; 230(6):653.e1-653.e17. PubMed ID: 38365100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
    N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
    Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
    Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
    Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
    Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of female sexual function in women who underwent abdominal or vaginal hysterectomy with or without bilateral salpingo-oophorectomy.
    Doğanay M; Kokanalı D; Kokanalı MK; Cavkaytar S; Aksakal OS
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):29-32. PubMed ID: 30445203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001.
    Robinson WR; Nichols HB; Tse CK; Olshan AF; Troester MA
    Am J Epidemiol; 2016 Sep; 184(5):388-99. PubMed ID: 27555487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient and Surgery Characteristics of Inpatient Hysterectomies Among Transgender Individuals.
    Colman DE; Beltran TG; Weber JM; Erkanli A; Robinson WR; Myers ER; Gray BA
    LGBT Health; 2023 Oct; 10(7):544-551. PubMed ID: 37252769
    [No Abstract]   [Full Text] [Related]  

  • 29. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients.
    Oseledchyk A; Gemignani ML; Zhou QC; Iasonos A; Elahjji R; Adamou Z; Feit N; Goldfarb SB; Long Roche K; Sonoda Y; Goldfrank DJ; Chi DS; Saban SS; Broach V; Abu-Rustum NR; Carter J; Leitao M; Zivanovic O
    Int J Gynecol Cancer; 2021 Feb; 31(2):222-231. PubMed ID: 33273020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
    Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
    Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
    Assaf W; Andraous M; Lavie O; Segev Y
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
    Wilson LF; Pandeya N; Byles J; Mishra GD
    Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
    Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
    JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
    Blustein P; Werner SR; Uppalapati P; Leung TM; Husk GA; Pereira EB; Whyte JS; Villella JA
    Am J Obstet Gynecol; 2023 Sep; 229(3):280.e1-280.e8. PubMed ID: 37308046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
    Lovett SM; Sandler DP; O'Brien KM
    J Natl Cancer Inst; 2023 Jun; 115(6):662-670. PubMed ID: 36806439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-cause and cardiovascular mortality after hysterectomy and oophorectomy in a large cohort (HUNT2).
    Michelsen TM; Rosland TE; Åsvold BO; Pripp AH; Liavaag AH; Johansen N
    Acta Obstet Gynecol Scand; 2023 Apr; 102(4):465-472. PubMed ID: 36814418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
    Obermair A; Youlden DR; Baade PD; Janda M
    Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
    Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
    Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of de novo cancer after premenopausal bilateral oophorectomy.
    Huo N; Smith CY; Gazzuola Rocca L; Rocca WA; Mielke MM
    Am J Obstet Gynecol; 2022 Apr; 226(4):539.e1-539.e16. PubMed ID: 34774521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.